Health Care [ 3/12 ] | Biotechnology [ 26/74 ]
NASDAQ | Common Stock
Dyne Therapeutics, Inc., a clinical-stage muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States.
It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics.
Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 4, 24 | -0.96 Increased by +2.75% | -0.71 Decreased by -35.61% |
| Aug 1, 24 | -0.70 Increased by +35.19% | -0.72 Increased by +2.78% |
| May 2, 24 | -0.81 Decreased by -3.85% | -0.80 Decreased by -1.25% |
| Mar 5, 24 | -1.09 Decreased by -47.30% | -0.92 Decreased by -18.48% |
| Oct 30, 23 | -0.99 Decreased by -23.75% | -0.83 Decreased by -19.28% |
| Aug 3, 23 | -1.08 Decreased by -6.93% | -0.81 Decreased by -33.33% |
| May 11, 23 | -0.78 Decreased by -13.04% | -0.77 Decreased by -1.30% |
| Mar 2, 23 | -0.74 Increased by +26.00% | -0.84 Increased by +11.90% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 0.00 Decreased by N/A% | -97.13 M Decreased by -61.31% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -65.10 M Decreased by -0.31% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -65.65 M Decreased by -54.48% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 3.79 M Increased by +N/A% | -66.64 M Decreased by -77.65% | Decreased by -1.76 K% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -60.21 M Decreased by -48.70% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -64.90 M Decreased by -25.17% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -42.50 M Decreased by -20.11% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -37.51 M Increased by +27.57% | Decreased by N/A% Decreased by N/A% |